CORONA Remedies to attend investor conference in London
CORONA Remedies Limited announced its participation in an investor conference in London on June 15-16, 2026, hosted by Kotak Institutional Equities. The event will feature 1x1 and group meetings based on publicly available information, with no disclosure of unpublished price sensitive information.

*this image is generated using AI for illustrative purposes only.
CORONA Remedies Limited will participate in an investor conference in London on June 15 and June 16, 2026, to engage with institutional investors. The meetings, organized by Kotak Institutional Equities, are scheduled to commence at 09:00 AM British Summer Time (BST) onwards. The company clarified that discussions during these sessions will be restricted to publicly available information, ensuring no unpublished price sensitive information (UPSI) is disclosed.
The conference will include both 1x1 meetings and group interactions. The disclosure was made to the stock exchanges in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Date and Time | Organized by | Nature of Conferences | Place |
|---|---|---|---|
| June 15, 2026 and June 16, 2026 09:00 AM (BST) Onwards |
Kotak Institutional Equities |
1x1 Meetings / Group | London, United Kingdom |
CORONA Remedies noted that the schedule is subject to change due to exigencies on the part of the host or the company. The intimation has been made available on the company's official website.
Historical Stock Returns for Corona Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.68% | +1.59% | -1.57% | +20.15% | +20.15% | +20.15% |
What strategic outcomes does CORONA Remedies aim to achieve by engaging with institutional investors in London?
How might the investor conference influence the company's stock liquidity and visibility in international markets?
What potential partnerships or market expansions could be explored during these interactions?


































